Global Organ Preservation Solutions Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Organ Preservation Solutions Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Organ Preservation Solutions report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Organ Preservation Solutions market is projected to reach US$ 246.5 million in 2034, increasing from US$ 125.2 million in 2022, with the CAGR of 9.7% during the period of 2024 to 2034. Demand from Hypothermic Perfusion Preservation (HPP) and Static Cold Storage (SCS) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Organ Preservation Solutions industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Organ Preservation Solutions key companies include Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB, ToleroTech, Inc, CryoLife, Inc. and Claris Lifesciences Limited, etc. Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific are top 3 players and held % share in total in 2022.
Organ Preservation Solutions can be divided into Viaspan, Custodial, siRNA Transplant Solutions and Others, etc. Viaspan is the mainstream product in the market, accounting for % share globally in 2022.
Organ Preservation Solutions is widely used in various fields, such as Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS) and Others,, etc. Hypothermic Perfusion Preservation (HPP) provides greatest supports to the Organ Preservation Solutions industry development. In 2022, global % share of Organ Preservation Solutions went into Hypothermic Perfusion Preservation (HPP) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Organ Preservation Solutions market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

Dr. Franz Köhler Chemie
Teva Pharmaceutical Industries Ltd.
Lifeline Scientific
Bristol-Myers Squibb
BioLife Solutions, Inc.
XVIVO Perfusion AB
ToleroTech, Inc
CryoLife, Inc.
Claris Lifesciences Limited
BioTime, Inc.
21st Century Medicine
Segment by Type
Viaspan
Custodial
siRNA Transplant Solutions
Others
Hypothermic Perfusion Preservation (HPP)
Static Cold Storage (SCS)
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Organ Preservation Solutions market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Organ Preservation Solutions introduction, etc. Organ Preservation Solutions Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Organ Preservation Solutions market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Organ Preservation Solutions industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Organ Preservation Solutions key companies include Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB, ToleroTech, Inc, CryoLife, Inc. and Claris Lifesciences Limited, etc. Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific are top 3 players and held % share in total in 2022.
Organ Preservation Solutions can be divided into Viaspan, Custodial, siRNA Transplant Solutions and Others, etc. Viaspan is the mainstream product in the market, accounting for % share globally in 2022.
Organ Preservation Solutions is widely used in various fields, such as Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS) and Others,, etc. Hypothermic Perfusion Preservation (HPP) provides greatest supports to the Organ Preservation Solutions industry development. In 2022, global % share of Organ Preservation Solutions went into Hypothermic Perfusion Preservation (HPP) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Organ Preservation Solutions market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report

By Company
Dr. Franz Köhler Chemie
Teva Pharmaceutical Industries Ltd.
Lifeline Scientific
Bristol-Myers Squibb
BioLife Solutions, Inc.
XVIVO Perfusion AB
ToleroTech, Inc
CryoLife, Inc.
Claris Lifesciences Limited
BioTime, Inc.
21st Century Medicine
Segment by Type
Viaspan
Custodial
siRNA Transplant Solutions
Others
Segment by Application
Hypothermic Perfusion Preservation (HPP)
Static Cold Storage (SCS)
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Organ Preservation Solutions market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Organ Preservation Solutions introduction, etc. Organ Preservation Solutions Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Organ Preservation Solutions market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
